Checks how scar depth after stomach tumor removal affects healing
Part of Cancer, Digestive system clinical trials.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 74.
- You have early stomach cancer (T1a) found on scope or ultrasound.
- The tumor type and size fit: no ulcer with certain size limits, or with ulcer only if small enough.
- Doctors say you need no further treatment right now after diagnosis.
- No serious bleeding, holes in the stomach, or other emergencies right now.
- No major bleeding/low clotting problems or severe heart, liver, or kidney disease that would make ESD unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medications, esomeprazole and sucralfate, to see if they help heal stomach ulcers after an endoscopic procedure (ESD) for early stomach cancer or pre-cancerous growths. It may help you if you need this procedure and have a larger ulcer afterwards.
This trial tests whether removing nearby lymph nodes is enough, or if additional stomach-sparing surgery is needed, after a previous endoscopic procedure did not completely remove early stomach cancer. The goal is to see which approach is better for preventing cancer from spreading.
This trial evaluates how useful a procedure called ESD is for patients as part of routine care. ESD is done during an endoscopy, and the study checks whether it works well and is helpful in the real world.
This study tests a new robot-assisted tool to remove early-stage stomach cancer or precancerous cells through a scope (endoscope) without open surgery. The goal is to see if it is safe and effective at removing the abnormal tissue completely.
This study follows people who had early-stage esophageal cancer removed with a minimally invasive procedure (ESD) to see how they do over time. It aims to understand how often the cancer comes back or spreads, and what factors might affect that.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.